My NCBISign In
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer, Jonathan Uhr
Breast Cancer Res. 2007; 9(5): R74. Published online 2007 October 26. doi: 10.1186/bcr1783
PMCID:
PMC2242672
Abstract Full Text PDF–158K

Is Cited by the Following 10 Articles in this Archive:

Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell, AmirAli H. Talasaz, Haiyu Zhang, Marc A. Coram, Anupama Reddy, Glenn Deng, Melinda L. Telli, Ranjana H. Advani, Robert W. Carlson, Joseph A. Mollick, Shruti Sheth, Allison W. Kurian, James M. Ford, Frank E. Stockdale, Stephen R. Quake, R. Fabian Pease, Michael N. Mindrinos, Gyan Bhanot, Shanaz H. Dairkee, Ronald W. Davis, Stefanie S. Jeffrey
PLoS One. 2012; 7(5): e33788. Published online 2012 May 7. doi: 10.1371/journal.pone.0033788
PMCID:
PMC3346739
Abstract Full Text PDF–1.2M Supplementary Material
Molecular Profiling of Individual Tumor Cells by Hyperspectral Microscopic Imaging
Jonathan W. Uhr, Michael L. Huebschman, Eugene P. Frenkel, Nancy L. Lane, Raheela Ashfaq, HuaYing Liu, Dipen R. Rana, Lawrence Cheng, Alice T. Lin, Gareth A. Hughes, Xiaojing J. Zhang, Harold R. Garner
Transl Res. Author manuscript; available in PMC 2013 May 1.
Published in final edited form as: Transl Res. 2012 May; 159(5): 366–375. Published online 2011 September 3. doi: 10.1016/j.trsl.2011.08.003
PMCID:
PMC3337082
Free in PMC on 2013/05/01
Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma
Katharina Pachmann, O. Camara, T. Kroll, M. Gajda, A. K. Gellner, J. Wotschadlo, I. B. Runnebaum
J Cancer Res Clin Oncol. 2011 September; 137(9): 1317–1327. Published online 2011 July 8. doi: 10.1007/s00432-011-1000-6
PMCID:
PMC3155034
Abstract Full Text PDF–486K
Detection of HER2 amplification in circulating free DNA in patients with breast cancer
K Page, N Hava, B Ward, J Brown, D S Guttery, C Ruangpratheep, K Blighe, A Sharma, R A Walker, R C Coombes, J A Shaw
Br J Cancer. 2011 April 12; 104(8): 1342–1348. Published online 2011 March 22. doi: 10.1038/bjc.2011.89
PMCID:
PMC3078598
Abstract Full Text PDF–417K
HER2-Positive Circulating Tumor Cells in Breast Cancer
Michail Ignatiadis, Françoise Rothé, Carole Chaboteaux, Virginie Durbecq, Ghizlane Rouas, Carmen Criscitiello, Jessica Metallo, Naima Kheddoumi, Sandeep K. Singhal, Stefan Michiels, Isabelle Veys, José Rossari, Denis Larsimont, Birgit Carly, Marta Pestrin, Silvia Bessi, Frédéric Buxant, Fabienne Liebens, Martine Piccart, Christos Sotiriou
PLoS One. 2011; 6(1): e15624. Published online 2011 January 10. doi: 10.1371/journal.pone.0015624
PMCID:
PMC3018524
Abstract Full Text PDF–243K Supplementary Material
Circulating tumour cells: their utility in cancer management and predicting outcomes
Matthew G. Krebs, Jian-Mei Hou, Tim H. Ward, Fiona H. Blackhall, Caroline Dive
Ther Adv Med Oncol. 2010 November; 2(6): 351–365. doi: 10.1177/1758834010378414
PMCID:
PMC3126032
Abstract Full Text PDF–126K
Herceptin functionalized microfluidic polydimethylsiloxane devices for the capture of human epidermal growth factor receptor 2 positive circulating breast cancer cells
Benjamin Thierry, Mahaveer Kurkuri, Jun Yan Shi, Lwin Ei Mon Phyo Lwin, Dennis Palms
Biomicrofluidics. 2010 September; 4(3): 032205. Published online 2010 September 30. doi: 10.1063/1.3480573
PMCID:
PMC2967203
Abstract Full Text PDF–917K
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Tanja Fehm, Oliver Hoffmann, Bahriye Aktas, Sven Becker, Erich F Solomayer, Diethelm Wallwiener, Rainer Kimmig, Sabine Kasimir-Bauer
Breast Cancer Res. 2009; 11(4): R59. Published online 2009 August 10. doi: 10.1186/bcr2349
PMCID:
PMC2750121
Abstract Full Text PDF–253K
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas, Mitra Tewes, Tanja Fehm, Siegfried Hauch, Rainer Kimmig, Sabine Kasimir-Bauer
Breast Cancer Res. 2009; 11(4): R46. Published online 2009 July 9. doi: 10.1186/bcr2333
PMCID:
PMC2750105
Abstract Full Text PDF–273K
A Splice Variant of HER2 Corresponding to Herstatin Is Expressed in the Noncancerous Breast and in Breast Carcinomas
Triantafyllia Koletsa, Ioannis Kostopoulos, Elpida Charalambous, Barbara Christoforidou, Eleni Nenopoulou, Vassiliki Kotoula
Neoplasia. 2008 July; 10(7): 687–696.
PMCID:
PMC2434206
Abstract Full Text PDF–1.3M
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk